Trials / Unknown
UnknownNCT03345758
Long Term Outcome of Extracorporeal Membrane Oxygenation Patients in China
Department of Critical Care Medicine, Nanjing Zhong-Da Hospital, Southeast University School of Medicine,China;
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 80 (estimated)
- Sponsor
- Southeast University, China · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Outcomes and Long-term Quality-of-life of Patients requiring Extracorporeal Membrane Oxygenation are not known in china. A prospective study survey will be performed to assess the long-term outcome of these patients.
Detailed description
Patients admitted to ICUs and treated with extracorporeal membrane oxygenation from March 1,2015 to March 1,2019 were screened . Pre-Ecmo clinical parameters(diagnose,APACHE-II, SOFA,indications,expected mortality) and related treatment conditions(duration of ICU stay, duration of ECMO,duration of mechanical ventilation,ventilation conditions,prone ventilation,ECMO complications )will be used to assess the severity and curative effect of these patients.Short Form-36 Health Status Questionnaire,EuroQol-5 Dimensions and St. George's Respiratory Questionnaire(SGRQ) will deliver in these survivors ,which are used to assess the physical and mental health ,as well as the social adaptation. Finally a comprehensive assessment will be obtained to describe the outcomes and long-term quality-of-life of patients treated With ECMO.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | outcome | telephone to patients to finish SF-36 (the MOS item short from health survey,SF-36),EQ-5D(EuroQol-5 Dimensions,EQ-5D), AMT-4(Abbreviated Mental Test-4,AMT-4)and MMSE(Mini-mental State Examination,MMSE) to make assessments of their physical and mental health, cognitive function and social adaptation after discharge |
Timeline
- Start date
- 2017-08-01
- Primary completion
- 2023-12-30
- Completion
- 2023-12-30
- First posted
- 2017-11-17
- Last updated
- 2022-07-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03345758. Inclusion in this directory is not an endorsement.